Sino Biopharmaceutical unit to buy 5% in CT Tianqing
Sino Biopharmaceutical says its SBP Group will acquire a 5% equity interest in CT Tianqing for RMB4.48 billion at 19X LTM P/E.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.